healthcare-thumbnail.png

Global AI in Healthcare Market Research Report – Segmented By End-User ( Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Payers & Reimbursement Organizations, Research Institutions, Remote Care Providers, Patients); By Application (Diagnostics (image analysis, pathology, etc.), Drug Discovery & Development, Treatment Planning & Support, Administrative Tasks & Workflow Optimization, Virtual Assistants & Chatbots, Telemedicine, Robotics); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

AI in Healthcare Market Size (2024 – 2030)

The Global AI in Healthcare Market was valued at USD 1.14 billion in 2023 and will grow at a CAGR of 6% from 2024 to 2030. The market is expected to reach USD 1.71 billion by 2030.

AI IN HEALTHCARE MARKET

Key Market Insights:

AI is expected to create 2 million new jobs in healthcare by 2030 highlighting the potential for new opportunities alongside potential disruption.Diagnostics (image analysis, pathology) holds the dominant market share of 80% according to internal estimates due to established applications in automating tasks and improving accuracy. North America is the current leader and has a 40% market share according to internal estimates. Asia Pacific is projected for the fastest growth CAGR of 45% according to internal estimates due to a rapidly growing healthcare sector and government initiatives. Hospitals & Clinics are the primary end-users with a 60% market share according to internal estimates and are driven by the pressure to improve patient outcomes and manage costs.

AI in Healthcare Market Drivers:

Big Data Boom and the Power of Information are driving the market

The healthcare industry sits on a treasure trove of data – patient medical records, diagnostic images, and even genetic information. This vast amount of complex data, however, can be overwhelming and difficult to analyze effectively. Here's where AI steps in as a powerful key that unlocks the hidden potential within this data. AI excels at sifting through massive datasets, identifying subtle patterns and trends that might escape even the most trained human eye. This analytical prowess empowers AI on multiple fronts. In diagnostics, AI can analyze medical images like X-rays and mammograms with exceptional accuracy, flagging potential abnormalities that might be missed by human radiologists. This can lead to earlier diagnoses, improved treatment outcomes, and potentially even saved lives. Furthermore, AI can analyze vast datasets of patient information to identify emerging disease outbreaks. By spotting trends in symptoms and geographic locations, AI can provide valuable insights to public health officials, allowing them to take proactive measures to contain outbreaks and mitigate their impact. Perhaps most importantly, AI can leverage patient data to usher in an era of personalized medicine. By analyzing an individual's unique genetic makeup and medical history, AI can help tailor treatment plans and therapies to their specific needs.

Efficiency Revolution: Streamlining Processes and Saving Costs is driving the market

Healthcare systems are bogged down by a mountain of administrative tasks – medical coding, billing, appointment scheduling, and insurance pre-authorizations. These repetitive, time-consuming processes divert valuable attention away from patient care. Here's where AI steps in as a game-changer. AI-powered automation can handle these tasks with speed and accuracy, freeing up doctors, nurses, and other healthcare professionals to focus on what they do best – providing care. Beyond automation, AI can optimize workflows by analyzing patient data and hospital operations to identify bottlenecks and inefficiencies. Imagine an AI system that predicts equipment failures before they happen, preventing disruptions in patient care. Additionally, AI can streamline logistics by managing inventory levels, optimizing supply chains, and ensuring the right equipment is available at the right time. These advancements translate into significant cost savings for healthcare providers. Freed from administrative burdens and operational inefficiencies, healthcare systems can redirect resources toward better patient care and improved overall efficiency.

Democratizing Access and Personalized Medicine is driving the market

The global healthcare landscape faces a critical challenge – a widening gap between the growing demand for care and the limited availability of qualified professionals. This is particularly acute in remote areas, where access to specialists can be scarce. AI presents a powerful solution to bridge this gap. AI-powered telehealth platforms can connect patients in remote locations with specialists in distant centers, enabling remote consultations and diagnoses. This not only improves access to care but also reduces the burden on local healthcare facilities. Furthermore, AI can play a vital role in preventative care. AI-powered chatbots and virtual assistants can guide patients through health screenings, answer questions about healthy habits, and offer medication reminders – all functions that can alleviate the strain on healthcare workers. Beyond access and support, AI is at the forefront of personalized medicine. By analyzing a patient's unique genetic and health data, AI can tailor treatment plans and therapies to their specific needs. This results in more effective interventions, fewer side effects, and ultimately, improved health outcomes for patients. In essence, AI has the potential to revolutionize healthcare delivery in underserved areas, empowering patients with proactive care and personalized treatment plans, all while easing the burden on overworked healthcare professionals.

Global AI in Healthcare Market challenges and restraints:

The rapid evolution of AI technology presents a challenge for regulators

The rapid evolution of AI technology presents a challenge for regulators. Existing regulations may not adequately address the unique risks and benefits of AI-powered healthcare solutions. Defining clear guidelines for data security, algorithm transparency, and liability remains a work in progress. This regulatory uncertainty can discourage investment and hinder innovation in the field.

Integrating AI into established healthcare workflows can be met with resistance from some healthcare professionals

Integrating AI into established healthcare workflows can be met with resistance from some healthcare professionals. Concerns about job displacement and a lack of trust in AI decision-making need to be addressed through effective training and communication. Additionally, a shortage of AI-literate healthcare professionals can impede the implementation and management of complex AI systems. Finally, the adoption of AI often requires significant investments in infrastructure, including high-performance computing power and data storage solutions. These factors can pose a challenge, particularly for smaller healthcare institutions.

Market Opportunities:

The global AI in the healthcare market presents a treasure trove of exciting opportunities. The ever-growing mountains of healthcare data, coupled with increasing computing power, create a fertile ground for AI innovation. We can expect advancements in areas like AI-powered drug discovery, which can significantly accelerate the development of life-saving medications. Additionally, AI can personalize treatment plans based on individual patient data, leading to more effective interventions and improved outcomes. Furthermore, AI-powered virtual assistants and chatbots can revolutionize patient education and support, providing 24/7 access to information and care navigation. Telemedicine powered by AI can expand access to care in remote areas, while AI-driven diagnostics hold immense promise for early disease detection and improved survival rates. The potential for cost savings through optimized workflows reduced administrative burdens and preventative care powered by AI is substantial. As regulatory frameworks catch up to technological advancements and public trust is built through responsible data practices, AI has the potential to democratize healthcare, improve efficiency, and revolutionize patient care on a global scale. This opens doors for a new era of healthcare – one that is more personalized, efficient, accessible, and ultimately, life-changing.

AI IN HEALTHCARE MARKET REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2023 - 2030

Base Year

2023

Forecast Period

2024 - 2030

CAGR

6%

Segments Covered

By End-User, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regional Scope

North America, Europe, APAC, Latin America, Middle East & Africa

Key Companies Profiled

IBM, Microsoft, Google, NVIDIA, Siemens Healthineers, Philips, GE Healthcare, Johnson & Johnson, Roche Diagnostics, Abbott Laboratories, Intel, Samsung

AI in Healthcare Market segmentation - By End-User

  • Hospitals & Clinics

  • Pharmaceutical & Biotechnology Companies

  • Payers & Reimbursement Organizations

  • Research Institutions

  • Remote Care Providers

  • Patients

Hospitals & Clinics currently hold the largest share. This is due to several factors. Hospitals face the constant pressure to improve patient outcomes while managing costs. AI offers solutions for both – improving diagnostics, optimizing workflows, and automating administrative tasks. Additionally, the vast amount of patient data readily available in hospitals provides a rich training ground for AI algorithms, further driving adoption in this segment.

AI in Healthcare Market segmentation - By Application

  • Diagnostics (image analysis, pathology, etc.)

  • Drug Discovery & Development

  • Treatment Planning & Support

  • Administrative Tasks & Workflow Optimization

  • Virtual Assistants & Chatbots

  • Telemedicine

  • Robotics

Currently, the most dominant segment in the global AI in healthcare market by application is split between two areas: Diagnostics (image analysis, pathology, etc.) and Robot-assisted surgery. Diagnostics holds the largest market share due to its established applications in tasks like analyzing medical images for early disease detection and assisting pathologists in cancer diagnosis. AI's ability to analyze vast amounts of data with high accuracy makes it a powerful tool for improving diagnostic accuracy and efficiency. However, Robot-assisted surgery is experiencing the fastest growth rate. AI's role in guiding surgical tools and assisting surgeons with complex procedures is leading to increased adoption. This segment is poised for continued significant growth in the coming years.

AI in Healthcare Market segmentation - Regional Analysis

  • North America

  • Asia-Pacific

  • Europe

  • South America

  • Middle East and Africa

North America reigns supreme in the global AI in the healthcare market. This dominance can be attributed to several factors. Firstly, North America boasts a well-established healthcare infrastructure with strong financial backing, allowing for significant investment in AI technology. Secondly, a supportive regulatory environment and a culture of early technology adoption further accelerate AI integration in healthcare. Additionally, the presence of leading AI research institutions and major healthcare IT companies in this region fuels innovation and market growth. However, the Asia Pacific region is projected to experience the fastest growth in the coming years due to factors like a rapidly growing healthcare sector, a large patient population, and increasing government initiatives promoting AI adoption in healthcare.

COVID-19 Impact Analysis on the Global AI in Healthcare Market

The COVID-19 pandemic acted as a catalyst for global AI in the healthcare market, accelerating its growth trajectory. While the initial lockdowns and economic disruptions caused temporary setbacks, the overall impact significantly boosted demand for AI-powered solutions. The ability of AI to analyze vast datasets, glean patient insights, and provide real-time predictions proved invaluable in managing the crisis. AI played a crucial role in tasks like identifying high-risk populations, tracking the virus's spread, and developing diagnostic tools using chest X-rays and CT scans. Furthermore, AI-powered chatbots answered patients' questions, alleviating pressure on overwhelmed healthcare workers. This surge in demand drove investments in AI research and the development of tools for drug discovery, virtual patient monitoring, and streamlining healthcare workflows. The pandemic highlighted the potential of AI to address critical challenges in healthcare delivery, leading to a long-term growth trend in the AI healthcare market. However, data privacy concerns and the high costs associated with AI development remain hurdles that need to be addressed for widespread adoption.

Latest trends/Developments

The latest trends in AI healthcare are shaping the future of personalized medicine and intelligent care. AI is going beyond disease detection in medical imaging with advancements in emotion AI for mental health assessments and early detection of conditions like autism. Telehealth is being revolutionized by AI-powered chatbots and virtual assistants that can answer patient queries, schedule appointments, and even monitor chronic conditions remotely. This allows for improved patient engagement and streamlines healthcare delivery. The holy grail of personalized medicine is being pursued with AI analyzing vast datasets to predict individual disease risks and tailor treatment plans. This is particularly promising in the field of oncology, where AI can analyze genetic information and medical history to suggest the most effective cancer therapies. Even hospital management is benefiting from AI, with robots assisting surgeons in complex procedures and AI algorithms optimizing hospital logistics and resource allocation. However, ethical considerations around data privacy and ensuring equitable access to AI-powered healthcare remain crucial areas to address.

Key Players:

  1. IBM

  2. Microsoft

  3. Google

  4. NVIDIA

  5. Siemens Healthineers

  6. Philips

  7. GE Healthcare

  8. Johnson & Johnson

  9. Roche Diagnostics

  10. Abbott Laboratories

  11. Intel

  12. Samsung

Chapter 1. AI in Healthcare Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. AI in Healthcare Market – Executive Summary
2.1    Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
                   2.2.1    Demand Side
                   2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. AI in Healthcare Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. AI in Healthcare Market - Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
                   4.5.1    Bargaining Power of Suppliers
                   4.5.2    Bargaining Powers of Customers
                   4.5.3    Threat of New Entrants
                   4.5.4    Rivalry among Existing Players
                   4.5.5    Threat of Substitutes 
Chapter 5. AI in Healthcare Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. AI in Healthcare Market – By End-Use Industry
6.1    Introduction/Key Findings   
6.2    Hospitals & Clinics
6.3    Pharmaceutical & Biotechnology Companies
6.4    Payers & Reimbursement Organizations
6.5    Research Institutions
6.6    Remote Care Providers
6.7    Patients
6.8    Y-O-Y Growth trend Analysis By End-Use Industry
6.9    Absolute $ Opportunity Analysis By End-Use Industry, 2024-2030 
Chapter 7. AI in Healthcare Market – By Application
7.1    Introduction/Key Findings   
7.2    Diagnostics (image analysis, pathology, etc.)
7.3    Drug Discovery & Development
7.4    Treatment Planning & Support
7.5    Administrative Tasks & Workflow Optimization
7.6    Virtual Assistants & Chatbots
7.7    Telemedicine
7.8    Robotics
7.9    Y-O-Y Growth  trend Analysis By Application
7.10    Absolute $ Opportunity Analysis By Application, 2024-2030  
Chapter 8. AI in Healthcare Market , By Geography – Market Size, Forecast, Trends & Insights
8.1    North America
                   8.1.1    By Country
                                      8.1.1.1    U.S.A.
                                      8.1.1.2    Canada
                                      8.1.1.3    Mexico
                   8.1.2    By End-Use Industry
                   8.1.3    By Application
                   8.1.4    Countries & Segments - Market Attractiveness Analysis
8.2    Europe
                   8.2.1    By Country
                                      8.2.1.1    U.K
                                      8.2.1.2    Germany
                                      8.2.1.3    France
                                      8.2.1.4    Italy
                                      8.2.1.5    Spain
                                      8.2.1.6    Rest of Europe
                   8.2.2    By End-Use Industry
                   8.2.3    By Application
                   8.2.4    Countries & Segments - Market Attractiveness Analysis
8.3    Asia Pacific
                   8.3.1    By Country
                                      8.3.1.1    China
                                      8.3.1.2    Japan
                                      8.3.1.3    South Korea
                                      8.3.1.4    India      
                                      8.3.1.5    Australia & New Zealand
                                      8.3.1.6    Rest of Asia-Pacific
                   8.3.2    By End-Use Industry
                   8.3.3    By Application
                   8.3.4    Countries & Segments - Market Attractiveness Analysis
8.4    South America
                   8.4.1    By Country
                                      8.4.1.1    Brazil
                                      8.4.1.2    Argentina
                                      8.4.1.3    Colombia
                                      8.4.1.4    Chile
                                      8.4.1.5    Rest of South America
                   8.4.2    By End-Use Industry
                   8.4.3    By Application
                   8.4.4    Countries & Segments - Market Attractiveness Analysis
8.5    Middle East & Africa
                   8.5.1    By Country
                                      8.5.1.1    United Arab Emirates (UAE)
                                      8.5.1.2    Saudi Arabia
                                      8.5.1.3    Qatar
                                      8.5.1.4    Israel
                                      8.5.1.5    South Africa
                                      8.5.1.6    Nigeria
                                      8.5.1.7    Kenya
                                      8.5.1.8    Egypt
                                      8.5.1.9    Rest of MEA
                   8.5.2    By End-Use Industry
                   8.5.3    By Application
                   8.5.4    Countries & Segments - Market Attractiveness Analysis 
Chapter 9. AI in Healthcare Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1    Diagnostics (image analysis, pathology, etc.)
9.2    Drug Discovery & Development
9.3    Treatment Planning & Support
9.4    Administrative Tasks & Workflow Optimization
9.5    Virtual Assistants & Chatbots
9.6    Telemedicine
9.7    Robotics


 

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Frequently Asked Questions

The Global AI in Healthcare Market was valued at USD 1.14 billion in 2023 and will grow at a CAGR of 6% from 2024 to 2030. The market is expected to reach USD 1.71 billion by 2030.

Big Data Boom and the Power of Information, Efficiency Revolution: Streamlining Processes and Saving Costs These are the reasons that are driving the market.

Based on End-User it is divided into six segments – Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Payers & Reimbursement Organizations, Research Institutions, Remote Care Providers

North America is the most dominant region for AI in the Healthcare Market.

IBM, Microsoft, Google, NVIDIA, Siemens Healthineers, and Philips are the key players.

Analyst Support

Every order comes with Analyst Support.

Customization

We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.